Drug intelligence / Profile preview

Bio-Herb Diabetes Formula

Development stage: Preclinical
Lead developer: La Croesus
Administration: Oral

Overview

Bio-Herb Diabetes Formula is an herbal medicine candidate developed by Bioherb for the treatment of Type 2 Diabetes. The formula is designed to regulate blood glucose levels and improve insulin sensitivity through a combination of botanical extracts. Bioherb, a Canadian biotechnology company, specializes in the development of natural health products and traditional medicine-based therapies. The product is currently listed in the company's development pipeline as a therapeutic option for metabolic disorders, leveraging proprietary extraction and formulation techniques to optimize the efficacy of its herbal components.

Brand names: Bio-Herb Diabetes Formula
Other names: Bio-Herb Diabetes Formula

Beyond the preview

Go deeper on Bio-Herb Diabetes Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Herb Diabetes Formula.

Explore the full profile